Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.82
-0.15 (-2.51%)
At close: Sep 15, 2026, 4:00 PM EDT
5.87
+0.05 (0.86%)
After-hours: Sep 15, 2026, 6:22 PM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $484.2 million as of September 15, 2026. Its market cap has increased by 456.53% in one year.
Market Cap
484.20M
Enterprise Value
431.59M
1-Year Change
456.53%
Ranking
Category
Stock Price
$5.82
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $484.20M, an increase of 2,177.25%. That is a compound annual growth rate of 70.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 484.20M | 249.30% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 525.35M |
| Autolus Therapeutics | 500.39M |
| Artiva Biotherapeutics | 499.66M |
| Zura Bio | 499.27M |
| Entera Bio | 491.72M |
| Capricor Therapeutics | 486.62M |
| Eikon Therapeutics | 484.24M |
| Relmada Therapeutics | 482.15M |